Table 2.
Maternal vitamin D markers | R2 | β (95% CI) | P | Significant Covariates4,5 | |
---|---|---|---|---|---|
| |||||
Maternal bone markers at baseline | |||||
1,25(OH)2D at baseline | NTx | 0.30 | −0.002 (−0.0043, −5.0e-6) | 0.050 | BMI |
1,25(OH)2D at baseline | DPD/Cr | 0.38 | 0.001 (0.0004, 0.002) | 0.010 | rs10741657 |
1,25(OH)2D at baseline | OC | 0.34 | 0.003 (0.0003, 0.006) | 0.035 | season, rs10741657 |
Free 25(OH)D at baseline | iPTH | 0.54 | −0.020 (−0.040, −0.001) | 0.040 | rs10741657, education |
Free 25(OH)D at baseline | ALP | 0.31 | 0.012 (−0.023, −0.0005) | 0.042 | rs7041 |
|
|||||
Maternal bone markers at study-end | |||||
|
|||||
Δ 25(OH)D6 | DPD/Cr | 0.49 | −0.009 (−0.016, −0.002) | 0.020 | age, rs10741657 |
Δ 25(OH)D6 | OC | 0.74 | −0.031 (−0.046, −0.017) | < 0.001 | BMI, gestational weight gain, rs10741657, rs12794714 |
1,25(OH)2D at baseline | DPD/Cr | 0.60 | 0.001 (0.0001, 0.002) | 0.033 | season, age, rs10741657 |
1,25(OH)2D at baseline | OC | 0.46 | 0.004 (0.002, 0.007) | 0.002 | season, rs10741657 |
1,25(OH)2D at study-end | NTx | 0.31 | −0.002 (−0.003, 4.4e-5) | 0.056 | BMI |
24,25(OH)2D at study-end | NTx | 0.68 | −0.061 (−0.126, 0.004) | 0.063 | ethnicity, gestational weight gain, rs10741657 |
Free 25(OH)D at study-end | NTx | 0.30 | −0.018 (−0.038, 0.001) | 0.062 | BMI |
Free 25(OH)D at study-end | ALP | 0.90 | −0.011 (−0.018, −0.004) | 0.004 | BMI, education, infant weight, infant length, rs7041 |
3-epi-25(OH)D3 at baseline | ALP | 0.92 | −0.078 (−0.119, −0.037) | 0.001 | BMI, ethnicity, season, infant weight, infant length, mode of delivery |
3-epi-25(OH)D3 at study-end | DPD/Cr | 0.56 | −0.040 (−0.075, −0.004) | 0.031 | age, infant length |
3-epi-25(OH)D3 at study-end | ALP | 0.49 | −0.058 (−0.093, −0.023) | 0.002 | BMI |
Δ 3-epi-25(OH)D36 | NTx | 0.72 | −0.104 (−0.020, −0.007) | 0.037 | BMI, rs10741657, rs7041, infant weight, infant head circumference |
|
|||||
Fetal bone markers at delivery | |||||
|
|||||
Δ 25(OH)D6 | OC | 0.83 | 0.042 (0.015, 0.068) | 0.005 | BMI, gestational weight gain, rs10741657, rs7041 |
24,25(OH)2D at study-end | CTx | 0.70 | 0.031 (0.007, 0.055) | 0.018 | BMI, ethnicity, gestational weight gain, infant weight, rs10741657, prestudy supplement use |
Free 25(OH)D at baseline | CTx | 0.53 | 0.008 (0.001, 0.015) | 0.021 | gestational weight gain, infant weight, infant length, rs10741657 |
Data were derived using linear mixed models which controlled for covariates.
All biochemical markers of bone turnover were log(ln)-transformed except for fetal CTx.
None of these associations achieved statistical significance among nonpregnant women.
Influential covariates which achieved statistical significance (P < 0.05) were retained in the final model of each outcome.
Two intake levels of dietary choline of this study did not achieve a statistical significance, and consequently, were not included in any of the final models.
Calculated by subtracting baseline values from study-end values.